Association of metformin use and new-onset ICD coding of neovascular age-related macular degeneration

Macular Diseases

Association of Mesopic and Dark-Adapted Retinal Sensitivity With Type 1 Macular Neovascularization in Age-Related Macular Degeneration

Invest Ophthalmol Vis Sci

Karaca I, Wei Y, Nelson R, Sassen SH, Daynes K, Clark F, Brown T, Messina A, Pfau M, Zhang Y, Schmitz-Valckenberg S, Fleckenstein M

doi: 10.1167/iovs.66.15.45

Macular DiseasesFurther Publications

Associations of Cardiovascular Health and New-Onset Age-Related Macular Diseases From UK Biobank

Invest Ophthalmol Vis Sci

Peng Y, Zhang Y, Kam KW, Wong G, Ho M, Sezto S, Au S, Zhang X, Ng MPH, Ip P, Young A, Pang CP, Tham CC, Chen LJ, Yam JC

doi: 10.1167/iovs.66.4.63

Macular Diseases

Prevalence and associated features of reticular pseudodrusen in neovascular age-related macular degeneration in an Asian population

Am J Ophthalmol

Kikushima W, Gilead N, Sherif MZA, Zhang C, Jiang Z, Sun C, Ong C, Hong CH, Teo KYC, Chakravarthy U, Cheung CMG

doi: 10.1016/j.ajo.2026.02.011

Macular Diseases

Evaluating the risk of recurrence in neovascular age-related macular degeneration using OCT-angiography at the time of treatment exit

Br J Ophthalmol

Jaggi D, Marugg S, Berger LE, Munk MR, Zinkernagel MS, Heussen FM

doi: 10.1136/bjo-2025-327721

Macular Diseases

TALON Phase IIIb Study: 32 Week Primary Results of Brolucizumab Using Treat and Extend for Neovascular Age Related Macular Degeneration

Ophthalmol Retina

Regillo C, Kaiser PK, Kertes PJ, Gillies M, Maio-Twofoot T, D'Souza D, Guenther S, Lawrence D, Holz FG

doi: 10.1016/j.oret.2025.05.030

Macular Diseases

Metformin and the Development of Age-Related Macular Degeneration

JAMA Ophthalmol

Jindal DA, Hanna J, Shaia JK, Markle J, Rachitskaya A, Kaelber DC, Singh RP, Talcott KE

doi: 10.1001/jamaophthalmol.2025.3070

Macular Diseases

Ten-Year Incidence, Risk Factors and Progression Rate of Macular Atrophy in Neovascular Age-Related Macular Degeneration

Clin Exp Ophthalmol

Romano F, Casaluci M, Valastro A, Airaldi M, Milella P, Pozzo Giuffrida F, Cozzi E, Aretti A, Teo KY, Cheung CMG, Nassisi M, Viola F, Staurenghi G, Invernizzi A

doi: 10.1111/ceo.14608

Macular DiseasesRetinal Diseases

Comparative diagnostic performance of six imaging modalities for detecting macular atrophy in neovascular age-related macular degeneration

Br J Ophthalmol

Olivieri C, Neri G, Ricardi F, Gelormini F, Fai A, Parisi G, Marolo P, Viggiano P, Boscia F, Reibaldi M, Borrelli E

doi: 10.1136/bjo-2025-328225

Macular Diseases

Cost-minimisation analysis of anti-VEGF therapies in neovascular age-related macular degeneration and diabetic macular oedema in Switzerland

J Med Econ

Ambresin A, Quist SW, Boer M, Maamari S, Barthelmes D

doi: 10.1080/13696998.2025.2536420

Related content

Association of Mesopic and Dark-Adapted Retinal Sensitivity With Type 1 Macular Neovascularization in Age-Related Macular Degeneration

Associations of Cardiovascular Health and New-Onset Age-Related Macular Diseases From UK Biobank

Prevalence and associated features of reticular pseudodrusen in neovascular age-related macular degeneration in an Asian population

Evaluating the risk of recurrence in neovascular age-related macular degeneration using OCT-angiography at the time of treatment exit

TALON Phase IIIb Study: 32 Week Primary Results of Brolucizumab Using Treat and Extend for Neovascular Age Related Macular Degeneration

Metformin and the Development of Age-Related Macular Degeneration

Ten-Year Incidence, Risk Factors and Progression Rate of Macular Atrophy in Neovascular Age-Related Macular Degeneration

Comparative diagnostic performance of six imaging modalities for detecting macular atrophy in neovascular age-related macular degeneration

Cost-minimisation analysis of anti-VEGF therapies in neovascular age-related macular degeneration and diabetic macular oedema in Switzerland